mRNA Vaccine Market Report

China mRNA Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 21, 2022
  • PAGES：140
  • REPORT CODE：GMM1056802
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China mRNA Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China mRNA Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by mRNA Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • eTheRNA

    • Ethris

    • Moderna Therapeutics

    • Translate Bio

    • CureVac

    • Tiba Biotechnology

    • Argos Therapeutics

    • BioNTech

    • Sangamo Therapeutics

    • In-Cell-Art

    By Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    By End-User:

    • Infectious Disease

    • Cancer

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China mRNA Vaccine Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2016 to 2027

    • 1.3.2 China mRNA Vaccine Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2016 to 2027

    • 1.3.3 China mRNA Vaccine Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2016 to 2027

    • 1.3.4 China mRNA Vaccine Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China mRNA Vaccine Market Size and Growth Rate of Infectious Disease from 2016 to 2027

    • 1.4.2 China mRNA Vaccine Market Size and Growth Rate of Cancer from 2016 to 2027

    • 1.4.3 China mRNA Vaccine Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of mRNA Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of mRNA Vaccine by Major Types

    • 3.4.1 Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    • 3.4.2 Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

    • 3.4.3 Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

    • 3.4.4 Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    4 Segmentation of mRNA Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of mRNA Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of mRNA Vaccine in Infectious Disease

    • 4.4.2 Market Size and Growth Rate of mRNA Vaccine in Cancer

    • 4.4.3 Market Size and Growth Rate of mRNA Vaccine in Other

    5 Market Analysis by Regions

    • 5.1 China mRNA Vaccine Production Analysis by Regions

    • 5.2 China mRNA Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China mRNA Vaccine Landscape Analysis

    • 6.1 North China mRNA Vaccine Landscape Analysis by Major Types

    • 6.2 North China mRNA Vaccine Landscape Analysis by Major End-Users

    7 Central China mRNA Vaccine Landscape Analysis

    • 7.1 Central China mRNA Vaccine Landscape Analysis by Major Types

    • 7.2 Central China mRNA Vaccine Landscape Analysis by Major End-Users

    8 South China mRNA Vaccine Landscape Analysis

    • 8.1 South China mRNA Vaccine Landscape Analysis by Major Types

    • 8.2 South China mRNA Vaccine Landscape Analysis by Major End-Users

    9 East China mRNA Vaccine Landscape Analysis

    • 9.1 East China mRNA Vaccine Landscape Analysis by Major Types

    • 9.2 East China mRNA Vaccine Landscape Analysis by Major End-Users

    10 Northeast China mRNA Vaccine Landscape Analysis

    • 10.1 Northeast China mRNA Vaccine Landscape Analysis by Major Types

    • 10.2 Northeast China mRNA Vaccine Landscape Analysis by Major End-Users

    11 Southwest China mRNA Vaccine Landscape Analysis

    • 11.1 Southwest China mRNA Vaccine Landscape Analysis by Major Types

    • 11.2 Southwest China mRNA Vaccine Landscape Analysis by Major End-Users

    12 Northwest China mRNA Vaccine Landscape Analysis

    • 12.1 Northwest China mRNA Vaccine Landscape Analysis by Major Types

    • 12.2 Northwest China mRNA Vaccine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 eTheRNA

      • 13.1.1 eTheRNA Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Ethris

      • 13.2.1 Ethris Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Moderna Therapeutics

      • 13.3.1 Moderna Therapeutics Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Translate Bio

      • 13.4.1 Translate Bio Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 CureVac

      • 13.5.1 CureVac Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Tiba Biotechnology

      • 13.6.1 Tiba Biotechnology Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Argos Therapeutics

      • 13.7.1 Argos Therapeutics Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 BioNTech

      • 13.8.1 BioNTech Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sangamo Therapeutics

      • 13.9.1 Sangamo Therapeutics Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 In-Cell-Art

      • 13.10.1 In-Cell-Art Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China mRNA Vaccine Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2016 to 2027

    • Figure China mRNA Vaccine Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2016 to 2027

    • Figure China mRNA Vaccine Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2016 to 2027

    • Figure China mRNA Vaccine Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China mRNA Vaccine Market Size and Growth Rate of Infectious Disease from 2016 to 2027

    • Figure China mRNA Vaccine Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure China mRNA Vaccine Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China mRNA Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of mRNA Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of mRNA Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of mRNA Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of mRNA Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of mRNA Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of mRNA Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Infectious Disease

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Other

    • Table China mRNA Vaccine Production by Regions

    • Table China mRNA Vaccine Production Share by Regions

    • Figure China mRNA Vaccine Production Share by Regions in 2016

    • Figure China mRNA Vaccine Production Share by Regions in 2021

    • Figure China mRNA Vaccine Production Share by Regions in 2027

    • Table China mRNA Vaccine Consumption by Regions

    • Table China mRNA Vaccine Consumption Share by Regions

    • Figure China mRNA Vaccine Consumption Share by Regions in 2016

    • Figure China mRNA Vaccine Consumption Share by Regions in 2021

    • Figure China mRNA Vaccine Consumption Share by Regions in 2027

    • Table North China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table North China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure North China mRNA Vaccine Consumption Share by Types in 2016

    • Figure North China mRNA Vaccine Consumption Share by Types in 2021

    • Figure North China mRNA Vaccine Consumption Share by Types in 2027

    • Table North China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table North China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure North China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure North China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure North China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table Central China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table Central China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Central China mRNA Vaccine Consumption Share by Types in 2016

    • Figure Central China mRNA Vaccine Consumption Share by Types in 2021

    • Figure Central China mRNA Vaccine Consumption Share by Types in 2027

    • Table Central China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table Central China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure Central China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure Central China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table South China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table South China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South China mRNA Vaccine Consumption Share by Types in 2016

    • Figure South China mRNA Vaccine Consumption Share by Types in 2021

    • Figure South China mRNA Vaccine Consumption Share by Types in 2027

    • Table South China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table South China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure South China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure South China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table East China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table East China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure East China mRNA Vaccine Consumption Share by Types in 2016

    • Figure East China mRNA Vaccine Consumption Share by Types in 2021

    • Figure East China mRNA Vaccine Consumption Share by Types in 2027

    • Table East China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table East China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure East China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure East China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure East China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table Northeast China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China mRNA Vaccine Consumption Share by Types in 2016

    • Figure Northeast China mRNA Vaccine Consumption Share by Types in 2021

    • Figure Northeast China mRNA Vaccine Consumption Share by Types in 2027

    • Table Northeast China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table Southwest China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table Southwest China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China mRNA Vaccine Consumption Share by Types in 2016

    • Figure Southwest China mRNA Vaccine Consumption Share by Types in 2021

    • Figure Southwest China mRNA Vaccine Consumption Share by Types in 2027

    • Table Southwest China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table Southwest China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure Southwest China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure Southwest China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table Northwest China mRNA Vaccine Consumption by Types from 2016 to 2027

    • Table Northwest China mRNA Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China mRNA Vaccine Consumption Share by Types in 2016

    • Figure Northwest China mRNA Vaccine Consumption Share by Types in 2021

    • Figure Northwest China mRNA Vaccine Consumption Share by Types in 2027

    • Table Northwest China mRNA Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northwest China mRNA Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China mRNA Vaccine Consumption Share by End-Users in 2016

    • Figure Northwest China mRNA Vaccine Consumption Share by End-Users in 2021

    • Figure Northwest China mRNA Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of eTheRNA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA

    • Figure Sales and Growth Rate Analysis of eTheRNA

    • Figure Revenue and Market Share Analysis of eTheRNA

    • Table Product and Service Introduction of eTheRNA

    • Table Company Profile and Development Status of Ethris

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris

    • Figure Sales and Growth Rate Analysis of Ethris

    • Figure Revenue and Market Share Analysis of Ethris

    • Table Product and Service Introduction of Ethris

    • Table Company Profile and Development Status of Moderna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

    • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

    • Figure Revenue and Market Share Analysis of Moderna Therapeutics

    • Table Product and Service Introduction of Moderna Therapeutics

    • Table Company Profile and Development Status of Translate Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Translate Bio

    • Figure Sales and Growth Rate Analysis of Translate Bio

    • Figure Revenue and Market Share Analysis of Translate Bio

    • Table Product and Service Introduction of Translate Bio

    • Table Company Profile and Development Status of CureVac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

    • Figure Sales and Growth Rate Analysis of CureVac

    • Figure Revenue and Market Share Analysis of CureVac

    • Table Product and Service Introduction of CureVac

    • Table Company Profile and Development Status of Tiba Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiba Biotechnology

    • Figure Sales and Growth Rate Analysis of Tiba Biotechnology

    • Figure Revenue and Market Share Analysis of Tiba Biotechnology

    • Table Product and Service Introduction of Tiba Biotechnology

    • Table Company Profile and Development Status of Argos Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics

    • Figure Sales and Growth Rate Analysis of Argos Therapeutics

    • Figure Revenue and Market Share Analysis of Argos Therapeutics

    • Table Product and Service Introduction of Argos Therapeutics

    • Table Company Profile and Development Status of BioNTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

    • Figure Sales and Growth Rate Analysis of BioNTech

    • Figure Revenue and Market Share Analysis of BioNTech

    • Table Product and Service Introduction of BioNTech

    • Table Company Profile and Development Status of Sangamo Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics

    • Figure Sales and Growth Rate Analysis of Sangamo Therapeutics

    • Figure Revenue and Market Share Analysis of Sangamo Therapeutics

    • Table Product and Service Introduction of Sangamo Therapeutics

    • Table Company Profile and Development Status of In-Cell-Art

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art

    • Figure Sales and Growth Rate Analysis of In-Cell-Art

    • Figure Revenue and Market Share Analysis of In-Cell-Art

    • Table Product and Service Introduction of In-Cell-Art


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US